Methyltestosterone-induced night blindness.
A 59-year-old man presented with a 3-month history of night blindness and a 9-month history of steatorrhea. Both symptoms had appeared after he had begun taking methyltestosterone. Investigations revealed low serum levels of carotene (0.1 mmol/L) and vitamin A (0.4 to 0.7 mmol/L), anomalous colour perception, elevation of the rod threshold by 3.5 log units in dark adaptometry, and decreased b-wave amplitudes in photopic and scotopic electroretinograms. No biochemical evidence of cholestasis was elicited. The symptoms and the biochemical and electrophysiologic abnormalities resolved within 9 months of the discontinuation of methyltestosterone.
D003118:Color Perception; D004596:Electroretinography; D007172:Erectile Dysfunction / Q000188:drug therapy; D006801:Humans; D008297:Male; D008777:Methyltestosterone / Q000009:adverse effects*; D008875:Middle Aged; D009755:Night Blindness / Q000209:etiology* / Q000503:physiopathology; D014802:Vitamin A Deficiency / Q000139:chemically induced* / Q000150:complications
D008777:Methyltestosterone